Cargando…

Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies

INTRODUCTION: We aimed to compare the predictive accuracy of surrogate indices namely the lipid accumulation product (LAP) index, homeostatic model of assessment of insulin resistance (HOMA-IR), fasting glucose-insulin ratio (FG-IR) and the quantitative-insulin sensitivity check index (QUICKI), agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Anoop S, Shajith, Dasgupta, Riddhi, Rebekah, Grace, Jose, Arun, Inbakumari, Mercy Prem, Finney, Geethanjali, Thomas, Nihal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449941/
https://www.ncbi.nlm.nih.gov/pubmed/34531243
http://dx.doi.org/10.1136/bmjdrc-2021-002414
_version_ 1784569519471067136
author Anoop S, Shajith
Dasgupta, Riddhi
Rebekah, Grace
Jose, Arun
Inbakumari, Mercy Prem
Finney, Geethanjali
Thomas, Nihal
author_facet Anoop S, Shajith
Dasgupta, Riddhi
Rebekah, Grace
Jose, Arun
Inbakumari, Mercy Prem
Finney, Geethanjali
Thomas, Nihal
author_sort Anoop S, Shajith
collection PubMed
description INTRODUCTION: We aimed to compare the predictive accuracy of surrogate indices namely the lipid accumulation product (LAP) index, homeostatic model of assessment of insulin resistance (HOMA-IR), fasting glucose-insulin ratio (FG-IR) and the quantitative-insulin sensitivity check index (QUICKI), against the M value of hyperinsulinemic-euglycemic clamp (HEC), and to determine a cut-off value for the LAP index to predict risk of insulin resistance in non-obese (body mass index <21 kg/m(2)), normoglycemic, Asian Indian males from Southern India. RESEARCH DESIGN AND METHODS: Data of HEC studies performed in 108 non-obese, normoglycemic, Asian Indian males was obtained retrospectively and the M value (a measure of whole-body insulin sensitivity) was calculated. The M value is the rate of whole-body glucose metabolism at the hyperinsulinemic plateau (a measure of insulin sensitivity) and is calculated between 60 and 120 min after the start of the insulin infusion in the HEC procedure. The LAP index, the HOMA-IR, FG-IR and QUICKI were calculated. Spearman’s correlation and logistic regression analysis were performed. Cut-off value for the LAP index was obtained using receiver operating characteristics with area under curve (AUC) analysis at 95% CI. P value <0.05 was considered to be statistically significant. RESULTS: Significant negative correlation was observed for the M value with LAP index (r=−0.39, p<0.001) while significant positive correlation was noted with FG-IR (r=0.25; p<0.01) and QUICKI (r=0.22; p<0.01). The LAP index cut-off value ≥33.4 showed 75% sensitivity and 75% specificity with AUC (0.72) to predict risk of insulin resistance in this cohort. CONCLUSION: The LAP index showed higher predictive accuracy for the risk of insulin resistance as compared with HOMA-IR, QUICKI and FG-IR in non-obese, normoglycemic Asian Indian males from Southern India.
format Online
Article
Text
id pubmed-8449941
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84499412021-10-01 Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies Anoop S, Shajith Dasgupta, Riddhi Rebekah, Grace Jose, Arun Inbakumari, Mercy Prem Finney, Geethanjali Thomas, Nihal BMJ Open Diabetes Res Care Cardiovascular and Metabolic Risk INTRODUCTION: We aimed to compare the predictive accuracy of surrogate indices namely the lipid accumulation product (LAP) index, homeostatic model of assessment of insulin resistance (HOMA-IR), fasting glucose-insulin ratio (FG-IR) and the quantitative-insulin sensitivity check index (QUICKI), against the M value of hyperinsulinemic-euglycemic clamp (HEC), and to determine a cut-off value for the LAP index to predict risk of insulin resistance in non-obese (body mass index <21 kg/m(2)), normoglycemic, Asian Indian males from Southern India. RESEARCH DESIGN AND METHODS: Data of HEC studies performed in 108 non-obese, normoglycemic, Asian Indian males was obtained retrospectively and the M value (a measure of whole-body insulin sensitivity) was calculated. The M value is the rate of whole-body glucose metabolism at the hyperinsulinemic plateau (a measure of insulin sensitivity) and is calculated between 60 and 120 min after the start of the insulin infusion in the HEC procedure. The LAP index, the HOMA-IR, FG-IR and QUICKI were calculated. Spearman’s correlation and logistic regression analysis were performed. Cut-off value for the LAP index was obtained using receiver operating characteristics with area under curve (AUC) analysis at 95% CI. P value <0.05 was considered to be statistically significant. RESULTS: Significant negative correlation was observed for the M value with LAP index (r=−0.39, p<0.001) while significant positive correlation was noted with FG-IR (r=0.25; p<0.01) and QUICKI (r=0.22; p<0.01). The LAP index cut-off value ≥33.4 showed 75% sensitivity and 75% specificity with AUC (0.72) to predict risk of insulin resistance in this cohort. CONCLUSION: The LAP index showed higher predictive accuracy for the risk of insulin resistance as compared with HOMA-IR, QUICKI and FG-IR in non-obese, normoglycemic Asian Indian males from Southern India. BMJ Publishing Group 2021-09-16 /pmc/articles/PMC8449941/ /pubmed/34531243 http://dx.doi.org/10.1136/bmjdrc-2021-002414 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Cardiovascular and Metabolic Risk
Anoop S, Shajith
Dasgupta, Riddhi
Rebekah, Grace
Jose, Arun
Inbakumari, Mercy Prem
Finney, Geethanjali
Thomas, Nihal
Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies
title Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies
title_full Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies
title_fullStr Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies
title_full_unstemmed Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies
title_short Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies
title_sort lipid accumulation product (lap) as a potential index to predict risk of insulin resistance in young, non-obese asian indian males from southern india: observations from hyperinsulinemic-euglycemic clamp studies
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449941/
https://www.ncbi.nlm.nih.gov/pubmed/34531243
http://dx.doi.org/10.1136/bmjdrc-2021-002414
work_keys_str_mv AT anoopsshajith lipidaccumulationproductlapasapotentialindextopredictriskofinsulinresistanceinyoungnonobeseasianindianmalesfromsouthernindiaobservationsfromhyperinsulinemiceuglycemicclampstudies
AT dasguptariddhi lipidaccumulationproductlapasapotentialindextopredictriskofinsulinresistanceinyoungnonobeseasianindianmalesfromsouthernindiaobservationsfromhyperinsulinemiceuglycemicclampstudies
AT rebekahgrace lipidaccumulationproductlapasapotentialindextopredictriskofinsulinresistanceinyoungnonobeseasianindianmalesfromsouthernindiaobservationsfromhyperinsulinemiceuglycemicclampstudies
AT josearun lipidaccumulationproductlapasapotentialindextopredictriskofinsulinresistanceinyoungnonobeseasianindianmalesfromsouthernindiaobservationsfromhyperinsulinemiceuglycemicclampstudies
AT inbakumarimercyprem lipidaccumulationproductlapasapotentialindextopredictriskofinsulinresistanceinyoungnonobeseasianindianmalesfromsouthernindiaobservationsfromhyperinsulinemiceuglycemicclampstudies
AT finneygeethanjali lipidaccumulationproductlapasapotentialindextopredictriskofinsulinresistanceinyoungnonobeseasianindianmalesfromsouthernindiaobservationsfromhyperinsulinemiceuglycemicclampstudies
AT thomasnihal lipidaccumulationproductlapasapotentialindextopredictriskofinsulinresistanceinyoungnonobeseasianindianmalesfromsouthernindiaobservationsfromhyperinsulinemiceuglycemicclampstudies